Published by:


FDA Approves Nerlynx (Neratinib) for a type of Breast Cancer

The US Food and Drug Administration (FDA) has approved the first extended adjuvant therapy for early-stage, HER2-postive breast cancer.

QR Code
Embed the QR code on your website:
Download
Copy